Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, International, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy and Safety of TTYP01 Tablets in Early Symptomatic Alzheimer's Disease

NCT07252440 is registered in ClinicalTrials.gov with Shanghai Auzone Biological Technology Co., Ltd. as lead sponsor.

NCT NCT07252440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07252440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, International, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy and Safety of TTYP01 Tablets in Early Symptomatic Alzheimer's Disease
Lead sponsor
Shanghai Auzone Biological Technology Co., Ltd.
Phase
Phase 2
Overall status
Recruiting
Start date
December 19, 2025
Completion date
November 23, 2028
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ad, early alzheimer's disease